#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters
For the first time, a pharmaceutical company has given generic manufacturers permission to make copies of an HIV medicine before the studies proving it works have... Read more.
Could NHI fuel anti-immigrant sentiment?
There is no government deadline. In fact, nothing exists outside of a fake flyer circulating on social media warning foreigners they will be arrested, detained or... Read more.
Could the NHI fuel anti-immigrant sentiment?
There is no government deadline. In fact, nothing exists outside of a fake flyer circulating on social media warning foreigners they will be arrested, detained or... Read more.
Here’s how to make drug addiction a health issue, not a criminal one
It’s still early when Bridget Munnik walks to work, and the streets of Westbury in Johannesburg are eerily quiet. “If it’s daylight, then it’s... Read more.
Can talks save South Africa’s NHI from a courtroom war?
Health Minister Aaron Motsoaledi has met with the South African Medical Association (Sama) – one of the organisations taking him to court about the National Health... Read more.
SA leading charge to make anti-HIV jab for Africa
South Africa’s National Aids Council ( Sanac) has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that... Read more.
Can SA fix its health system before courts decide its fate?
Less than two years after President Cyril Ramaphosa signed the National Health Insurance Act (NHI) into law in May 2024, South Africa’s most ambitious health... Read more.
How to decode Big Tobacco’s illicit trade fiction
On the front lines of the Tobacco Bill battle, the first salvo of the year was launched. British American Tobacco South Africa (Batsa) announced in January that... Read more.
Obesity: the chronic disease that isn’t treated like one
A study about weight loss medications that was published in the British Medical Journal in January didn’t seem like good news. Oxford researchers looked at 37... Read more.
The anti-HIV jab Buhle trusts – and 456 000 South Africans can soon get for free
For the past three years, Buhle Sikade (22) has been using an injection—called lenacapavir (LEN)—that gives her almost foolproof protection against getting... Read more.
